Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 470-090-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- Storage No.: EX0307
Chemical name: 1-[(3 -Aminopropyl)dimethyl-silyl]-2,2dimethyl- 1-aza-2-sila cyclopentane
Physical State at RT: liquid
Storage conditions: ambient, RT, protected from light
Safety precautions: Routine hygienic procedures were sufficient
to assure personnel health and safety.
Test animals
- Species:
- rat
- Strain:
- other: HsdBrl:WH Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Hsd:Wistar rats (HsdBrl:WH,Full-Barrier), Sex: male and female.
Step 1: 3 male animals were used, body weight at the commencement of the study: 166 - 183 g
Step 2: 3 female animals were used, body weight at the commencement of the study: 154 - 158 g.
Step 3: 3 male animals were used, body weight at the commencement of the study: 169 - 183 g
The animals were derived from a controlled full barrier maintained breeding system (spf).
Source: Harlan Winke1mann GmbH, D-33178 Borchen.
The animals were barrier maintained (semi-barrier) in air conditioned rooms
- Temperature: 22 ± 3° C
- ReI. humidity: 55 ± 10%
- Artificial light, lighting regime 12 : 12 hours, light 6.00 - 18.00
- Air change: 10 x / hour
- Feeding ad libitum, Altromin 1324 maintenance diet for rats and mice, totally-pathogen-free (TPF)
- Free access to tap water (drinking water, municipal residue control, microbiol. controlled periodically)
- The animals were kept in Macrolon cages on Altromin saw fiber bedding
- Adequate acclimatization period
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The test item was administered in a single dose by gavage using an intubation cannula.
Volume of application: The test item was applied according to body-weight at a volume of 10 ml/kg bw. - Doses:
- The starting dose (step 1 and 2) was 200 mg/kg body weight. Since no compound-related mortality was found further testing was required.
According to OECD Guideline 423 the next step (step 3) was performed at the dose level of 2000 mg/kg body weight. According to the acute toxic
class method regime no further testing was required. - No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- Weight Assessment
The animals were weighed prior to first application and once a week thereafter.
Clinical Examination
A careful clinical examination was made twice a day on the day of dosing and once a day thereafter.
Cageside observations included changes in the skin and fur, eyes and mucous membranes. Also respiratory, circulatory, autonomic and central nervous systems and somatomotor activity and behaviour pattern were examined. Particular attention was directed to observations of tremor, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Pathology
At the end of the observation period the animals were sacrificed by an overdosage of pentobarbital. All animals were subjected to gross necropsy. All gross pathological changes were recorded.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 3 animals at a dose of 2000 mg/kg bw.
- Clinical signs:
- no signs observed in survivng animals
- Body weight:
- within normal range
- Gross pathology:
- no findings
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Considering the reported data of this toxicity test it can be stated that the test item has acute toxic characteristics. The LD50 was determined to be between 300 and 500 mg/kg bw.
- Executive summary:
The acute toxic class method was performed with the test item. It is the principle of the acute toxic class method that, based on a stepwise procedure with the use of a minimum number of animals per step, sufficient information is obtained on the acute toxicity of the test item to enable its classification.
In the first step the test item was given in a dose of 200 mg/kg body weight to a group of 3 male rats (HsdBr1:WH Wistar) in a single
exposure via oral gavage. In a second step the test item was given in a dose of 200 mg/kg body weight to a group of 3 female rats (HsdBr1:WH Wistar) in a single exposure via oral gavage, because all male animals were still alive 24 h p. appl. without any clinical symptoms.
The dosage of 200 mg/kg bw caused no compound-related mortality neither in the three male nor in the three female animals.
A careful clinical examination was made once a day. At the end of the observation period the animals were sacrificed and necropsy was carried out to record gross pathological changes. No clinical signs of toxicity were observed throughout the observation period.
Beside acute injection ofblood vessels in the abdominal region, which is due to the euthanasia injection no special gross pathological changes were found in all animals of step 1 and step 2.
Throughout the 14-days observation period no weight loss was recorded in the animals of step 1 and 2. According to the acute toxic class method regime, in a third step the test item was given to a further group of three male animals in a dose of2000 mg/kg bw.
The dosage of 2000 mg/kg bw caused compound-related mortality in the three male animals of step 3 within 90 minutes p. appl..
Necropsy was carried out to record gross pathological changes. The following special gross pathological change was found in all animals of step 3: Mucous membrane was completely bloody.
According to the acute toxic class method regime, no further testing was required. According to the results obtained the LDso was determined to be between 300 and 500 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.